For years, metformin has been the go-to medicine for millions of people living with type 2 diabetes. It is affordable, widely available and has a long track record of helping control blood sugar.
But diabetes treatment is changing rapidly. Medicines such as Ozempic and Mounjaro have transformed the conversation around diabetes, offering not just better blood sugar control but also significant weight-loss benefits.
So, is metformin becoming outdated? Are the newer injections more effective? And should everyone with type 2 diabetes consider switching to them?
The important thing to understand is that these medicines work differently. And the most expensive or newest treatment is not necessarily the best one for every patient.
Metformin: The Established Diabetes Medicine
Metformin has been used in diabetes care for decades and remains an important medicine for managing type 2 diabetes. It primarily works by reducing the amount of glucose produced by the liver. It also improves the body's sensitivity to insulin, helping cells use glucose more effectively.
Its biggest advantages are:
- It is relatively affordable and widely available.
- It has a well-established safety record.
- It generally does not cause low blood sugar when used on its own.
- It is usually weight-neutral or may lead to modest weight loss.
However, metformin can cause gastrointestinal side effects such as nausea, bloating and diarrhoea, particularly when treatment begins. Long-term use can also lower vitamin B12 levels in some people.
Dr Misra points out that metformin continues to have an important place in diabetes treatment. It has not become obsolete simply because newer medicines are available.
For many patients, it remains part of their treatment plan, sometimes in combination with newer drugs.
Ozempic: More Than A Blood Sugar Medicine
Ozempic contains semaglutide, which belongs to a class of medicines called GLP-1 receptor agonists. These medicines mimic the action of a naturally occurring gut hormone called GLP-1.
They work in several ways:
- Stimulate insulin release when blood sugar is high.
- Reduce the release of glucagon, a hormone that raises blood sugar.
- Slow stomach emptying.
- Act on appetite pathways, helping people feel fuller and eat less.
One of its major advantages is that it can help with both blood sugar control and weight management.
Semaglutide has also demonstrated cardiovascular benefits in certain people with type 2 diabetes and established cardiovascular disease. Specific semaglutide treatment has also shown kidney-related benefits in people with type 2 diabetes and chronic kidney disease.
However, Ozempic is not a routine weight-loss injection for everyone. It is a prescription medicine requiring medical assessment and monitoring.
Mounjaro: How Is It Different From Ozempic?
Mounjaro contains tirzepatide, which works differently from semaglutide.
While Ozempic targets one hormone pathway, GLP-1, Mounjaro targets two: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide).
This makes tirzepatide a dual GIP and GLP-1 receptor agonist.
Both hormones play a role in regulating blood sugar and appetite.
Mounjaro helps the body release insulin when glucose levels are high, reduces glucagon secretion, improves glucose regulation and helps reduce food intake.
Clinical trials have demonstrated substantial improvements in blood sugar control and body weight with tirzepatide in people with type 2 diabetes.
In head-to-head clinical research, tirzepatide has also demonstrated greater reductions in HbA1c and body weight than semaglutide at the doses studied. However, individual results vary, and trial comparisons should not be interpreted as a guarantee of what every patient will experience.
This does not automatically make Mounjaro the right choice for everyone. Cost, side effects, medical history and treatment goals all matter.
Metformin vs Ozempic vs Mounjaro: At A Galnce
What is it?
- Metformin: Traditional diabetes tablet.
- Ozempic: Newer diabetes injection.
- Mounjaro: Newer diabetes injection.
How does it work?
- Metformin: Reduces sugar produced by the liver.
- Ozempic: Acts on the GLP-1 hormone.
- Mounjaro: Acts on both GIP and GLP-1 hormones.
How is it taken?
- Metformin: Tablet, usually daily.
- Ozempic: Injection, once weekly.
- Mounjaro: Injection, once weekly.
Effect on weight
- Metformin: Usually weight-neutral; modest weight loss is possible.
- Ozempic: Can lead to significant weight loss.
- Mounjaro: Can lead to significant weight loss.
Main benefit
- Metformin: Affordable and effective blood sugar control.
- Ozempic: Blood sugar control and appetite reduction.
- Mounjaro: Blood sugar control and substantial weight-loss potential.
Cost
- Metformin: Generally inexpensive.
- Ozempic: More expensive.
- Mounjaro: More expensive.
Who Should Consider Which Medicine?
There is no single diabetes medicine that works best for everyone. The choice depends on the patient's blood sugar levels, weight, medical history, risk of complications and ability to afford and continue treatment.
Metformin may be suitable for:
- People who need an established, affordable treatment.
- Patients who need help controlling blood sugar.
- People for whom significant weight loss is not the primary treatment goal.
Semaglutide may be considered for:
- People who need additional blood sugar control.
- Patients with type 2 diabetes who also have overweight or obesity.
- Selected patients with cardiovascular disease or chronic kidney disease who may benefit from its additional protective effects.
Tirzepatide may be considered for:
- People who need substantial improvement in blood sugar control.
- Patients with type 2 diabetes and obesity or excess weight.
- Those who need additional support with weight management alongside diabetes treatment.
Importantly, these medicines are not always alternatives to one another. Metformin may be continued alongside newer injectable medicines, depending on the patient's needs.
Current diabetes guidelines increasingly recommend choosing treatment based not just on HbA1c, but also on weight, cardiovascular health, kidney function, affordability and other individual factors.
What About Side Effects And Long-Term Use?
This is an important consideration before starting either Ozempic or Mounjaro.
Both can cause gastrointestinal side effects, including:
- Nausea
- Vomiting
- Diarrhoea
- Constipation
- Abdominal discomfort
These symptoms are often more noticeable when treatment begins or doses are increased.
Less common but potentially serious concerns include pancreatitis and gallbladder-related problems. These medicines are not suitable for everyone and require medical assessment.
Another important question is what happens when patients stop taking them.
Weight regain and a rise in blood sugar can occur after discontinuation, particularly if the underlying metabolic condition remains. This is why patients should not start these medicines expecting a short-term fix.
Diabetes and obesity often require long-term management, with treatment reviewed regularly.
Are These Medicines Becoming Weight-Loss Shortcuts?
The popularity of Ozempic and Mounjaro has extended beyond diabetes clinics, with growing interest in their weight-loss effects. But there is a difference between medically supervised treatment and using prescription medicines for cosmetic weight loss.
These are powerful metabolic medicines, not lifestyle shortcuts.
Patients need an assessment of their blood sugar, weight, medical history and potential contraindications before starting treatment.
Diet, physical activity, sleep and long-term behavioural changes remain essential parts of diabetes management, even when medication is prescribed.
So, Which Diabetes Drug Is Better?
There is no universal winner.
Metformin remains an important and effective medicine because of its affordability, accessibility and established safety profile.
Semaglutide and tirzepatide offer additional benefits, particularly for people who need greater blood sugar control and weight management. Semaglutide also has established cardiovascular and kidney benefits in specific patient groups.
The arrival of newer medicines does not mean older treatments have become obsolete. Instead, diabetes care is moving towards individualised treatment, where doctors consider the patient's overall metabolic health rather than focusing only on blood sugar numbers.
The bottom line here is not to choose a diabetes medicine because it is trending or because someone else has lost weight on it. The right treatment depends on your blood sugar, weight, heart and kidney health, medical history and long-term goals.
This World Diabetes Day, understanding the difference between metformin, ozempic and mounjaro is an important first step towards making informed treatment decisions.
Disclaimer: This content including advice provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information.